CTRI/2019/03/018248招募中4 期
An open label, multicenter, Phase-IV clinical trial to evaluate disease response of Carfilzomib Injection with patients relapsed or refractory multiple myeloma who have received one to three lines of therapy
atco Pharma Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Patients aged >=18 years
- •2. Relapsed and/or refractory multiple myeloma at study entry.(It is defined either the lack of response or disease progression on or within 60 day of the last therapy)
- •3. Received one, but not more than three prior treatment regimens or lines of therapy for multiple myeloma
排除标准
- •1. Glucocorticoid therapy (prednisone >10 mg/day orally or equivalent) within the last three weeks
- •2.POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)
- •3. Plasma cell leukemia
- •4. Chemotherapy with approved or investigative anticancer therapeutics, including steroid therapy, within the three weeks prior to first dose
- •5. Radiation therapy or immunotherapy in the previous four weeks, localized radiation therapy within 1 week prior to first dose
- •6. Participation in an investigational therapeutic study within three weeks or within five drug half-lives (t1/2) prior to first dose, whichever time is greater
研究者
相似试验
尚未招募
4 期
An open label, multicenter, Phase-IV clinical trial to evaluate the safety and efficacy of Daclatasvir and Sofosbuvir in patients with Chronic Hepatitis C genotype 3 infection.CTRI/2018/03/012297ATCO Pharma Limited
进行中（未招募）
1 期
Prospective, Multicenter, Open-label Phase IV trial of Trifluridine/Tipiracil to Evaluate the Health-related Quality of Life in Patients with Metastatic Colorectal CancerHistologically or cytologically confirmed UICC stage IV carcinoma of colon or rectum with metastasis (metastatic colorectal cancer) with need for treatment due to progressionEUCTR2017-000292-83-DEServier Deutschland GmbH195
已完成
4 期
Prospective, Multicenter, Open-label Phase IV trial of Trifluridine/Tipiracil to Evaluate the Health-related Quality of Life in Patients with Metastatic Colorectal Cancer.metastatic colorectal cancer (mCRC)C18C19C20Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumDRKS00012977Servier Deutschland GmbH202
进行中（未招募）
不适用
A multi-centre, open-label, clinical, phase 4 trial, following on from a head-to-head comparison study of two H1N1 influenza vaccines in children, to compare firstly, the persistence of antibody against the A/California/7/2009 (H1N1) virus and secondly the immunogenicity and reactogenicity of one dose of a non-adjuvanted trivalent seasonal influenza vaccine, in children who had received a two-dose immunisation regimen of Celvapan or Pandemrix. - Swine Flu (Influenza A H1N1) follow on Vaccine Study Version 1Prevention of Influenza infectionsMedDRA version: 12.0Level: LLTClassification code 10059429Term: Influenza immunisationEUCTR2010-022817-24-GBniversity of Oxford
已完成
2 期
An open-label, Phase I/II multicenter clinical trial of VXM01 in combination with avelumab in patients with progressive glioblastoma following standard treatment, with or without second surgery.GlioblastomaNL-OMON48738VAXIMM GmbH9